As of 2025-06-18, the Relative Valuation of Astellas Pharma Inc (4503.T) is 463.06 JPY. This relative valuation is based on P/E multiples. With the latest stock price at 1,383.00 JPY, the upside of Astellas Pharma Inc based on Relative Valuation is -66.5%.
The range of the Relative Valuation is 364.77 - 657.87 JPY.
| Range | Selected | |
| Trailing P/E multiples | 15.7x - 23.5x | 19.0x |
| Forward P/E multiples | 17.8x - 20.9x | 19.2x |
| Fair Price | 364.77 - 657.87 | 463.06 |
| Upside | -73.6% - -52.4% | -66.5% |
| Date | P/E |
| 2025-06-16 | 49.41 |
| 2025-06-13 | 49.51 |
| 2025-06-12 | 50.51 |
| 2025-06-11 | 50.60 |
| 2025-06-10 | 50.55 |
| 2025-06-09 | 50.01 |
| 2025-06-06 | 49.78 |
| 2025-06-05 | 49.76 |
| 2025-06-04 | 50.48 |
| 2025-06-03 | 50.92 |
| 2025-06-02 | 50.80 |
| 2025-05-30 | 50.96 |
| 2025-05-29 | 50.41 |
| 2025-05-28 | 49.94 |
| 2025-05-27 | 50.09 |
| 2025-05-26 | 49.80 |
| 2025-05-23 | 49.67 |
| 2025-05-22 | 49.59 |
| 2025-05-21 | 49.21 |
| 2025-05-20 | 48.66 |
| 2025-05-19 | 49.02 |
| 2025-05-16 | 48.71 |
| 2025-05-15 | 47.82 |
| 2025-05-14 | 48.27 |
| 2025-05-13 | 48.93 |
| 2025-05-12 | 47.86 |
| 2025-05-09 | 49.78 |
| 2025-05-08 | 50.21 |
| 2025-05-07 | 51.05 |
| 2025-05-02 | 51.99 |
| 2025-05-01 | 51.32 |
| 2025-04-30 | 50.91 |
| 2025-04-28 | 51.17 |
| 2025-04-25 | 49.26 |
| 2025-04-24 | 48.52 |
| 2025-04-23 | 48.78 |
| 2025-04-22 | 48.12 |
| 2025-04-21 | 47.62 |
| 2025-04-18 | 48.23 |
| 2025-04-17 | 47.32 |
| 2025-04-16 | 47.16 |
| 2025-04-15 | 47.68 |
| 2025-04-14 | 46.82 |
| 2025-04-11 | 45.27 |
| 2025-04-10 | 47.55 |
| 2025-04-09 | 44.83 |
| 2025-04-08 | 47.82 |
| 2025-04-07 | 46.41 |
| 2025-04-04 | 49.57 |
| 2025-04-03 | 49.05 |